bisoprolol has been researched along with Body Weight in 12 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Body weight increased significantly in the carvedilol group (mean change + 2." | 9.13 | Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. ( Gobec, L; Kovacić, D; Lainscak, M; Marinsek, M; Podbregar, M, 2008) |
| "The cardioprotective effects of bisoprolol were studied in a rat model of severe heart failure induced by autoimmune myocarditis." | 7.71 | Bisoprolol improves survival in rats with heart failure. ( Aizawa, Y; Fuse, K; Hanawa, H; Hasegawa, G; Inoue, M; Ito, M; Kato, K; Kodama, M; Ma, M; Naito, M; Nakazawa, M; Ohta, Y; Wahed, MI; Watanabe, K, 2001) |
| "Body weight increased significantly in the carvedilol group (mean change + 2." | 5.13 | Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. ( Gobec, L; Kovacić, D; Lainscak, M; Marinsek, M; Podbregar, M, 2008) |
| "In a double-blind crossover study, the influence of bisoprolol and placebo was tested in 20 noninsulin-dependent diabetics with concomitant essential hypertension." | 5.06 | Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin A1 in noninsulin-dependent diabetics. ( Disselhoff, G; Janka, HU; Mehnert, H; Ziegler, AG, 1986) |
| "The cardioprotective effects of bisoprolol were studied in a rat model of severe heart failure induced by autoimmune myocarditis." | 3.71 | Bisoprolol improves survival in rats with heart failure. ( Aizawa, Y; Fuse, K; Hanawa, H; Hasegawa, G; Inoue, M; Ito, M; Kato, K; Kodama, M; Ma, M; Naito, M; Nakazawa, M; Ohta, Y; Wahed, MI; Watanabe, K, 2001) |
| "Bisoprolol (60 mg/kg body weight per day) was given 30 min or 14 days after MI or sham operation." | 3.70 | Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. ( Ertl, G; Gaudron, P; Hu, K, 1998) |
| "Body weight was monitored at weekly intervals and kept constant within +/- 1 kg of the subjects' baseline weight throughout the entire study period." | 2.68 | Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity. ( Ampudia, J; Brunner, G; Heinemann, L; Heise, T; Sawicki, P; Sindelka, G; Starke, AA, 1995) |
| "Treatment with bisoprolol prevented the progression of cardiac dysfunction in TO-2 hamsters." | 1.33 | Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy. ( Hashimoto, K; Ichihara, G; Ichihara, S; Iwase, M; Kanazawa, H; Kato, Y; Matsushita, A; Oikawa, S; Yamada, Y; Yokota, M, 2006) |
| "Treatment with bisoprolol or captopril largely prevented all of these changes in infarcted hearts." | 1.30 | Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction. ( de Groot, M; Dienesch, C; Ertl, G; Horn, M; Hu, K; Hügel, S; Neubauer, S; Remkes, H, 1999) |
| "In bisoprolol-treated animals, systolic blood pressure did not change and was even significantly higher than in controls." | 1.29 | Life survival and cardiovascular structures following selective beta-blockade in spontaneously hypertensive rats. ( Benetos, A; Levy, BI; Poitevin, P; Prost, PL; Safar, ME, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Springer, J | 1 |
| Tschirner, A | 1 |
| Haghikia, A | 1 |
| von Haehling, S | 1 |
| Lal, H | 1 |
| Grzesiak, A | 1 |
| Kaschina, E | 1 |
| Palus, S | 1 |
| Pötsch, M | 1 |
| von Websky, K | 1 |
| Hocher, B | 1 |
| Latouche, C | 1 |
| Jaisser, F | 1 |
| Morawietz, L | 1 |
| Coats, AJ | 1 |
| Beadle, J | 1 |
| Argiles, JM | 1 |
| Thum, T | 1 |
| Földes, G | 1 |
| Doehner, W | 1 |
| Hilfiker-Kleiner, D | 1 |
| Force, T | 1 |
| Anker, SD | 1 |
| Altoama, K | 1 |
| Yassine Mallem, M | 1 |
| Thorin, C | 1 |
| Betti, E | 1 |
| Desfontis, JC | 1 |
| Podbregar, M | 2 |
| Voga, G | 1 |
| Minami, N | 1 |
| Yoshikawa, T | 1 |
| Kataoka, H | 1 |
| Mori, N | 1 |
| Nagasaka, M | 1 |
| Kurosawa, H | 1 |
| Kanazawa, M | 1 |
| Kohzuki, M | 1 |
| Ichihara, S | 1 |
| Yamada, Y | 1 |
| Ichihara, G | 1 |
| Kanazawa, H | 1 |
| Hashimoto, K | 1 |
| Kato, Y | 1 |
| Matsushita, A | 1 |
| Oikawa, S | 1 |
| Yokota, M | 1 |
| Iwase, M | 1 |
| Kovacić, D | 1 |
| Marinsek, M | 1 |
| Gobec, L | 1 |
| Lainscak, M | 1 |
| Heinemann, L | 1 |
| Heise, T | 1 |
| Ampudia, J | 1 |
| Sawicki, P | 1 |
| Sindelka, G | 1 |
| Brunner, G | 1 |
| Starke, AA | 1 |
| Benetos, A | 1 |
| Poitevin, P | 1 |
| Prost, PL | 1 |
| Safar, ME | 1 |
| Levy, BI | 1 |
| Hu, K | 2 |
| Gaudron, P | 1 |
| Ertl, G | 2 |
| Hügel, S | 1 |
| Horn, M | 1 |
| de Groot, M | 1 |
| Remkes, H | 1 |
| Dienesch, C | 1 |
| Neubauer, S | 1 |
| Watanabe, K | 1 |
| Ohta, Y | 1 |
| Inoue, M | 1 |
| Ma, M | 1 |
| Wahed, MI | 1 |
| Nakazawa, M | 1 |
| Hasegawa, G | 1 |
| Naito, M | 1 |
| Fuse, K | 1 |
| Ito, M | 1 |
| Kato, K | 1 |
| Hanawa, H | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
| Janka, HU | 1 |
| Ziegler, AG | 1 |
| Disselhoff, G | 1 |
| Mehnert, H | 1 |
4 trials available for bisoprolol and Body Weight
| Article | Year |
|---|---|
Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Aged; Basal Metabolism; Bisoprolol; Blood Pressure; Bod | 2002 |
Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Blood Glucose; Body Weight; Carbazoles; Carvedilol; C | 2008 |
Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Body Weigh | 1995 |
Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin A1 in noninsulin-dependent diabetics.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Blood Glucose; Blood Pressure; Body Weight; Carbohydr | 1986 |
8 other studies available for bisoprolol and Body Weight
| Article | Year |
|---|---|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolo | 2014 |
Effect of nebivolol treatment during pregnancy on the genital circulation, fetal growth and postnatal development in the Wistar rat.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Bisoprolol; Blood Pressure; Body Weight; Female; Fe | 2015 |
Effects of exercise and beta-blocker on blood pressure and baroreflexes in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Baroreflex; Bisoprolol; Blood Pressure; Body Weight; | 2003 |
Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy.
Topics: Aldehydes; Animals; Antioxidants; Bisoprolol; Blood Pressure; Body Weight; Cardiomyopathy, Dilated; | 2006 |
Life survival and cardiovascular structures following selective beta-blockade in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Arteries; Bisoprolol; Blood Pressure; Body Weight; Card | 1994 |
Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Body Weight; Disease Models, Animal; Dose-Response | 1998 |
Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Adrenergic beta-Antagonists; Angiotensin-Converting Enz | 1999 |
Bisoprolol improves survival in rats with heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Body Weight; Fibrosis; Heart Failure; Hemodynamics | 2001 |